Prophylactic use of nasalferon against COVID-19 in healthcare workers. Early surveillance study

Introduction: In Cuba, the nasal application of recombinant human IFN-alpha- 2b (nasalferon) began in personnel at risk in order to prevent SARS-CoV-2 infection. Objective: To characterize the safety in those subjects exposed to the use of Nasalferon at the Surgical Medical Research Center and to e...

Full description

Bibliographic Details
Main Authors: Julio César Hernández Perera, Natalia Planas Sliuntiaeva, Susana Portela Collazo, Yadira Elvira Peña Guerra, Anselmo Antonio Abdo Cuza, Roberto Castellanos Gutiérrez, Mayka Caridad Guerrero Cancio, Dania Piñeiro Pérez, Ángela Tuero Iglesias
Format: Article
Language:English
Published: Universidad de Ciencias Médicas de La Habana 2022-05-01
Series:Revista Habanera de Ciencias Médicas
Subjects:
Online Access:http://www.revhabanera.sld.cu/index.php/rhab/article/view/4759